Roche to Buy InterMune for $8.3B

Aug. 25 (Bloomberg) –- Bloomberg’s Phil Serafino reports on Roche, the world’s largest maker of cancer drugs, buying InterMune and what it means for the industry. He speaks to Manus Cranny on “Countdown.” (Source: Bloomberg)

Most Recent Videos

Bareburger CEO Responds to Shake Shack IPO
58:19 - Jan. 30 -- Bareburger CEO Euripides Pelekanos discusses how he will expand the Bareburger brand with Bloomberg's Pimm Fox on "Taking Stock."
  • How Apple Conquered China Market: Bloomberg West (01/30)
  • Should Amazon Spin Off Its Growing Cloud Business?
  • TripAdvisor's Top Pick: Chicago's Langham Hotel